Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
United Microelectronic
UMC
$57.2B
| $50.4M | 0.04% |
19,102,139
+942,659
| +5% | +$2.37M |
2013 Q2
28 quarters
|
|
427
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$159B
| $50.3M | 0.04% |
8,945,070
-177,700
| -2% | -$960K |
2013 Q2
28 quarters
|
|
428
OGE Energy
OGE
$9.53B
| $50.3M | 0.04% |
1,655,764
-344,797
| -17% | -$10.7M |
2013 Q4
26 quarters
|
|
429
Diageo
DEO
$48.4B
| $50.2M | 0.04% |
373,733
+14,133
| +4% | +$1.94M |
2017 Q2
12 quarters
|
|
430
Illumina
ILMN
$40B
| $50M | 0.04% |
138,910
+137,985
| +14,917% | +$44.4M |
2020 Q1
1 quarter
|
|
431
COPT Defense Properties
CDP
$3.8B
| $49.8M | 0.04% |
1,964,888
-767,000
| -28% | -$19.1M |
2014 Q4
22 quarters
|
|
432
Lockheed Martin
LMT
$117B
| $49.6M | 0.04% |
135,800
-7,622
| -5% | -$2.88M |
2018 Q4
6 quarters
|
|
433
Keurig Dr Pepper
KDP
$42.5B
| $49M | 0.04% |
1,726,381
+1,212,281
| +236% | +$32.9M |
2019 Q2
4 quarters
|
|
434
Annaly Capital Management
NLY
$13.8B
| $48.8M | 0.04% |
1,859,791
-1,112,075
| -37% | -$27.5M |
2014 Q3
23 quarters
|
|
|
TARO
435
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $48.8M | 0.04% |
733,600
+67,600
| +10% | +$4.53M |
2013 Q2
28 quarters
|
|
436
Radware
RDWR
$1.24B
| $48.6M | 0.04% |
2,061,339
+179,100
| +10% | +$4.11M |
2014 Q3
23 quarters
|
|
437
Kearny Financial
KRNY
$581M
| $48.5M | 0.04% |
5,923,609
+23,090
| +0.4% | +$193K |
2013 Q2
28 quarters
|
|
438
British American Tobacco
BTI
$119B
| $48.4M | 0.04% |
1,247,154
+50,601
| +4% | +$1.94M |
2014 Q2
24 quarters
|
|
439
Vanda Pharmaceuticals
VNDA
$274M
| $48.4M | 0.04% |
4,229,822
+380,168
| +10% | +$4.3M |
2015 Q4
18 quarters
|
|
440
WSFS Financial
WSFS
$3.85B
| $48.3M | 0.04% |
1,683,631
-342,631
| -17% | -$9.07M |
2013 Q2
28 quarters
|
|
|
EGOV
441
DELISTED
NIC Inc
EGOV
| $48.2M | 0.04% |
2,098,132
+334,760
| +19% | +$7.92M |
2018 Q3
7 quarters
|
|
442
Boston Properties
BXP
$9.47B
| $47.9M | 0.04% |
530,400
+131,503
| +33% | +$11.9M |
2018 Q3
7 quarters
|
|
443
Crown Castle
CCI
$29.3B
| $47.9M | 0.04% |
286,303
-1,422,288
| -83% | -$229M |
2015 Q1
21 quarters
|
|
444
Vale
VALE
$57.1B
| $47.6M | 0.04% |
4,618,390
-17,005,259
| -79% | -$156M |
2016 Q1
17 quarters
|
|
445
Enanta Pharmaceuticals
ENTA
$352M
| $47.3M | 0.04% |
942,900
+62,300
| +7% | +$3.22M |
2016 Q1
17 quarters
|
|
446
Abbott
ABT
$170B
| $47.2M | 0.04% |
+515,966
| New | +$46.6M |
2020 Q2
0 quarters
|
|
447
AT&T
T
$170B
| $47M | 0.04% |
2,057,610
-11,506,089
| -85% | -$262M |
2020 Q1
1 quarter
|
|
|
CAJ
448
DELISTED
Canon, Inc.
CAJ
| $46.9M | 0.04% |
2,348,977
+699,470
| +42% | +$14.5M |
2013 Q2
28 quarters
|
|
449
3M
MMM
$84.4B
| $46.8M | 0.04% |
+358,680
| New | +$45.2M |
2020 Q2
0 quarters
|
|
450
Alcoa
AA
$11.3B
| $46.8M | 0.04% |
4,160,688
-2,804,200
| -40% | -$25.1M |
2019 Q1
5 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.